Switch From Oral Iron to Intravenous Ferric Carboxymaltose in Non-dialysis Chronic Kidney Disease (CKD)

NCT02232906 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Iron Deficiency
Anaemia

Interventions

DRUG: intravenous ferric carboxymaltose

Sponsor

Hospital Aleman

Collaborators

[object Object]